Continuous or Batch: Deciding on the Best Solution for your Oral Solid Dose Product
Continuous manufacturing enables the development of a more diverse pipeline of drug products by greater quality assurance, reduced API usage, and timeline efficiencies. It also reduces scaleup activities as a product increases in volume in the clinical phase through commercial. With that comes the benefits of reduced API usage, and therefore costs. Additional benefits include timeline efficiencies as well as a reduction of technical risks, as continuous manufacturing systems are designed with integrated solutions that allow for real-time analysis and control.